Nestlé Health Science has acquired a stake in a US firm Accera, to support the ongoing trials and rollout of the firm's key brand, Axona, a medical food intended for the clinical dietary management of mild to moderate Alzheimer's disease, already on the market in the USA.
Axona fits the company's ambition to develop a strong portfolio of nutrition-based solutions to manage and prevent disease.
Read the full story: www.nestle.com/Media/NewsAndFeatures/Pages/Nestle-Health-Science-brain-health-Accera-acquisition.aspx
Read the announcement on the Nestlé Health Science website: www.nestlehealthscience.com/newsroom
More Nestlé news: www.nestle.com